PuSH - Publication Server of Helmholtz Zentrum München

Niespodziana, K.* ; Borochova, K.* ; Pazderova, P.* ; Schlederer, T.* ; Astafyeva, N.* ; Baranovskaya, T.* ; Barbouche, M.R.* ; Beltyukov, E.* ; Berger, A.* ; Borzova, E.* ; Bousquet, J.* ; Bumbacea, R.S.* ; Bychkovskaya, S.* ; Caraballo, L.* ; Chung, K.F.* ; Custovic, A.* ; Docena, G.* ; Eiwegger, T.* ; Evsegneeva, I.* ; Emelyanov, A.* ; Errhalt, P.* ; Fassakhov, R.* ; Fayzullina, R.* ; Fedenko, E.* ; Fomina, D.* ; Gao, Z.* ; Giavina-Bianchi, P.* ; Gotua, M.* ; Greber-Platzer, S.* ; Hedlin, G.* ; Ilina, N.* ; Ispayeva, Z.* ; Idzko, M.* ; Johnston, S.L.* ; Kalayci, Ö.* ; Karaulov, A.* ; Karsonova, A.* ; Khaitov, M.* ; Kovzel, E.* ; Kowalski, M.L.* ; Kudlay, D.* ; Levin, M.* ; Makarova, S.* ; Matricardi, P.M.* ; Nadeau, K.C.* ; Namazova-Baranova, L.* ; Naumova, O.* ; Nazarenko, O.* ; O'Byrne, P.M.* ; Osier, F.* ; Pampura, A.N.* ; Panaitescu, C.* ; Papadopoulos, N.G.* ; Park, H.S.* ; Pawankar, R.* ; Pohl, W.* ; Renz, H.* ; Riabova, K.* ; Sampath, V.* ; Sekerel, B.E.* ; Sibanda, E.* ; Siroux, V.* ; Sizyakina, L.P.* ; Sun, J.L.* ; Szepfalusi, Z.* ; Umanets, T.* ; Van Bever, H.P.S.* ; van Hage, M.* ; Vasileva, M.* ; von Mutius, E. ; Wang, J.Y.* ; Wong, G.W.K.* ; Zaikov, S.* ; Zidarn, M.*

Toward personalization of asthma treatment according to trigger factors.

J. Allergy Clin. Immunol. 145, 1529-1534 (2020)
Postprint DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Asthma is a severe and chronic disabling disease affecting more than 300 million people worldwide. Although in the past few drugs for the treatment of asthma were available, new treatment options are currently emerging, which appear to be highly effective in certain subgroups of patients. Accordingly, there is a need for biomarkers that allow selection of patients for refined and personalized treatment strategies. Recently, serological chip tests based on microarrayed allergen molecules and peptides derived from the most common rhinovirus strains have been developed, which may discriminate 2 of the most common forms of asthma, that is, allergen- and virus-triggered asthma. In this perspective, we argue that classification of patients with asthma according to these common trigger factors may open new possibilities for personalized management of asthma.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Corresponding Author
Keywords Asthma ; Allergy ; Wheeze ; Rhinovirus ; Allergen ; Microarray; Allergen; Sensitization; Children; Immunotherapy; Infections; Responses; Antibody; Epitope; Atopy; Risk
ISSN (print) / ISBN 0091-6749
e-ISSN 1097-6825
Journal The journal of allergy and clinical immunology
Quellenangaben Volume: 145, Issue: 6, Pages: 1529-1534 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam [u.a.]
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Asthma and Allergy Prevention (IAP)